Clinical Trial Update: Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. [NA]

View source ↗

Summary

Clinical trial investigating exosome analyses in cerebrospinal fluid for breast cancer patients with suspected leptomeningeal metastasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastasis

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer, Leptomeningeal Metastasis | NA | Status: WITHDRAWN